93 related articles for article (PubMed ID: 9365174)
1. Breast cancer risk estimation in families with history of breast cancer.
Muhonen T; Eerola H; Vehmanen P; Nevanlinna H; Aktan K; Blomqvist C; Kääriäinen H; Pyrhönen S
Br J Cancer; 1997; 76(9):1228-31. PubMed ID: 9365174
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of breast cancer in families in Iceland.
Tulinius H; Sigvaldason H; Olafsdóttir G; Tryggvadóttir L
J Med Genet; 1992 Mar; 29(3):158-64. PubMed ID: 1552557
[TBL] [Abstract][Full Text] [Related]
4. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
Tryggvadottir L; Sigvaldason H; Olafsdottir GH; Jonasson JG; Jonsson T; Tulinius H; Eyfjörd JE
J Natl Cancer Inst; 2006 Jan; 98(2):116-22. PubMed ID: 16418514
[TBL] [Abstract][Full Text] [Related]
5. Epidemiologic and genetic follow-up study of 544 Minnesota breast cancer families: design and methods.
Sellers TA; Anderson VE; Potter JD; Bartow SA; Chen PL; Everson L; King RA; Kuni CC; Kushi LH; McGovern PG
Genet Epidemiol; 1995; 12(4):417-29. PubMed ID: 8536958
[TBL] [Abstract][Full Text] [Related]
6. Validation of family history of breast cancer and identification of the BRCA1 and other syndromes using a population-based cancer registry.
Anton-Culver H; Kurosaki T; Taylor TH; Gildea M; Brunner D; Bringman D
Genet Epidemiol; 1996; 13(2):193-205. PubMed ID: 8722746
[TBL] [Abstract][Full Text] [Related]
7. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of susceptibility to breast cancer.
Hulka BS
Prog Clin Biol Res; 1996; 395():159-74. PubMed ID: 8895988
[TBL] [Abstract][Full Text] [Related]
9. The effect of a single BRCA2 mutation on cancer in Iceland.
Tulinius H; Olafsdottir GH; Sigvaldason H; Arason A; Barkardottir RB; Egilsson V; Ogmundsdottir HM; Tryggvadottir L; Gudlaugsdottir S; Eyfjord JE
J Med Genet; 2002 Jul; 39(7):457-62. PubMed ID: 12114473
[TBL] [Abstract][Full Text] [Related]
10. [Heterogeneity of breast cancer].
Gencík A; Castaño Almendral A; Ludwig H; Weber W; Müller H
Soz Praventivmed; 1986; 31(4-5):221-3. PubMed ID: 3765867
[TBL] [Abstract][Full Text] [Related]
11. Cancer incidence in first-degree relatives of a population-based set of cases of early-onset breast cancer.
Rawal R; Bertelsen L; Olsen JH
Eur J Cancer; 2006 Nov; 42(17):3034-40. PubMed ID: 16996259
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer family history as a risk factor for early onset breast cancer.
Lynch HT; Watson P; Conway T; Fitzsimmons ML; Lynch J
Breast Cancer Res Treat; 1988 Jul; 11(3):263-7. PubMed ID: 3167232
[TBL] [Abstract][Full Text] [Related]
13. Population-based relative risks for specific family history constellations of breast cancer.
Albright FS; Kohlmann W; Neumayer L; Buys SS; Matsen CB; Kaphingst KA; Cannon-Albright LA
Cancer Causes Control; 2019 Jun; 30(6):581-590. PubMed ID: 31030355
[TBL] [Abstract][Full Text] [Related]
14. Segregation analysis of 389 Icelandic pedigrees with Breast and prostate cancer.
Baffoe-Bonnie AB; Kiemeney LA; Beaty TH; Bailey-Wilson JE; Schnell AH; Sigvaldason H; Olafsdóttir G; Tryggvadóttir L; Tulinius H
Genet Epidemiol; 2002 Nov; 23(4):349-63. PubMed ID: 12432503
[TBL] [Abstract][Full Text] [Related]
15. Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status.
Tutera AM; Sellers TA; Potter JD; Drinkard CR; Wiesner GL; Folsom AR
Genet Epidemiol; 1996; 13(2):207-21. PubMed ID: 8722747
[TBL] [Abstract][Full Text] [Related]
16. Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families.
Sellers TA; King RA; Cerhan JR; Chen PL; Grabrick DM; Kushi LH; Oetting WS; Vierkant RA; Vachon CM; Couch FJ; Therneau TM; Olson JE; Pankratz VS; Hartmann LC; Anderson VE
Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1051-7. PubMed ID: 10613336
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database.
Slattery ML; Kerber RA
JAMA; 1993 Oct; 270(13):1563-8. PubMed ID: 8371466
[TBL] [Abstract][Full Text] [Related]
18. Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers?
Semple J; Metcalfe KA; Lubinski J; Huzarski T; Gronwald J; Armel S; Lynch HT; Karlan B; Foulkes W; Singer CF; Neuhausen SL; Eng C; Iqbal J; Narod SA;
Breast Cancer Res Treat; 2015 Nov; 154(1):163-9. PubMed ID: 26467043
[TBL] [Abstract][Full Text] [Related]
19. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.
Berry DA; Parmigiani G; Sanchez J; Schildkraut J; Winer E
J Natl Cancer Inst; 1997 Feb; 89(3):227-38. PubMed ID: 9017003
[TBL] [Abstract][Full Text] [Related]
20. The genetic epidemiology of second primary breast cancer.
Bernstein JL; Thompson WD; Risch N; Holford TR
Am J Epidemiol; 1992 Oct; 136(8):937-48. PubMed ID: 1456270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
